Harwood Feffer LLP Announces Investigation of Amicus Therapeutics, Inc.

NEW YORK, Oct. 9, 2015 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Amicus Therapeutics, Inc. ("Amicus" or the "Company") (NASDAQ: FOLD), concerning whether the board has breached its fiduciary duties to shareholders.

On September 2, 2015, Amicus issued an upbeat press release about the outcome of a meeting with the U.S. Food and Drug Administration ("FDA") regarding the New Drug Application for the Company's product candidate, migalastat. 

On October 2, 2015, the Company issued a press release titled "Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy," in which it retracted its previous description of the FDA feedback described in September in light of, among other things, the "final FDA minutes" from the same September meeting. 

The Company's stock dropped significantly on this disclosure and has lost approximately 66% of its value since its September 2015 highs.

Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.

If you own Amicus shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com  
Website: http://www.hfesq.com  
Follow us on Twitter: @HarwoodFeffer

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm. 

The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO

 

SOURCE Harwood Feffer LLP